Wei-Qiao Liu
Overview
Explore the profile of Wei-Qiao Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Liu W, Hosseinpour Z, Pike G, Cerchiaro G, Greenfield J, et al.
Mult Scler Relat Disord
. 2024 Mar;
85:105525.
PMID: 38461731
Background: Identification of therapies to promote repair in multiple sclerosis is challenged by the lack of an accepted trial model and associated outcome measures. The goal of this study was...
2.
Hosseinpour Z, Oladosu O, Liu W, Pike G, Yong V, Metz L, et al.
Front Neurol
. 2023 Aug;
14:1213377.
PMID: 37638198
Background And Goal: characterization of brain lesion types in multiple sclerosis (MS) has been an ongoing challenge. Based on verified texture analysis measures from clinical magnetic resonance imaging (MRI), this...
3.
Oladosu O, Liu W, Brown L, Pike B, Metz L, Zhang Y
Front Hum Neurosci
. 2022 Aug;
16:944908.
PMID: 36034111
Introduction: Disease development in multiple sclerosis (MS) causes dramatic structural changes, but the exact changing patterns are unclear. Our objective is to investigate the differences in brain structure locally and...
4.
Oladosu O, Liu W, Pike B, Koch M, Metz L, Zhang Y
Front Neurosci
. 2021 May;
15:634063.
PMID: 34025338
Tissue pathology in multiple sclerosis (MS) is highly complex, requiring multi-dimensional analysis. In this study, our goal was to test the feasibility of obtaining high angular resolution diffusion imaging (HARDI)...
5.
Koch M, Mostert J, Greenfield J, Liu W, Metz L
J Neurol
. 2020 May;
267(9):2619-2624.
PMID: 32388832
Background: Epidemiological, pathological and radiological studies suggest that inflammatory demyelination in MS is an age-dependent process, and that the formation of focal inflammatory demyelinating lesions decreases with age. Gadolinium-enhancing lesions...
6.
Tang L, Zhou Y, Zhu S, Liang G, Zhuang H, Zhao M, et al.
BMC Med Genomics
. 2020 Apr;
13(1):59.
PMID: 32252754
Background: Escherichia coli are mostly commensals but also contain pathogenic lineages. It is largely unclear whether the commensal E. coli as the potential origins of pathogenic lineages may consist of...
7.
Kennedy A, Beland B, Brust T, Liu W, Camara-Lemarroy C
Can J Neurol Sci
. 2020 Feb;
47(3):422-424.
PMID: 32046808
No abstract available.
8.
Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity
Camara-Lemarroy C, Silva C, Greenfield J, Liu W, Metz L, Yong V
Mult Scler
. 2019 Jul;
26(11):1340-1350.
PMID: 31317818
Background: Recent evidence suggests a role for the gut-brain axis in the pathophysiology of multiple sclerosis (MS). Materials And Methods: We studied biomarkers of intestinal permeability in 126 people with...
9.
Koch M, Liu W, Camara-Lemarroy C, Zhang Y, Pike G, Metz L, et al.
J Neuroimmunol
. 2019 Jun;
334:576974.
PMID: 31174092
Increasing systemic prolactin levels improves remyelination and neuronal survival in animal models of Multiple Sclerosis (MS), but it has been suggested that this therapeutic strategy may also increase inflammatory responses,...
10.